Financial statements Klemt-Pharma
Balance sheet of Klemt-Pharma
Company age:
Age:
24 y. 6 m. 15 d.
Share capital:
Share capital:
4 000 PLN
Balance sheet data of KLEMT-PHARMA
|
Year
|
2021
|
2022
|
2023
|
2024
|
|---|---|---|---|---|
| Total assets | 3 957 232,54 | 3 322 683,09 | 3 292 771,22 | 2 626 719,13 |
| A. Fixed assets | 150 682,29 | 133 033,56 | 205 158,98 | 178 544,06 |
| B. Current assets | 3 806 550,25 | 3 189 649,53 | 3 087 612,24 | 2 448 175,07 |
| C. Share capital contributions (basic funds) | 0,00 | - | - | 0,00 |
| D. Own shares (stocks) | 0,00 | - | - | 0,00 |
| Total liabilities | 3 957 232,54 | 3 322 683,09 | 3 292 771,22 | 2 626 719,13 |
| A. Equity | 1 024 142,26 | 1 032 509,80 | 1 377 162,64 | 1 355 975,71 |
| B. Liabilities and provisions for liabilities | 2 933 090,28 | 2 290 173,29 | 1 915 608,58 | 1 270 743,42 |
| I. Long-term liabilities | 0,00 | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 2 933 090,28 | 2 290 173,29 | 1 915 608,58 | 1 270 743,42 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.